Voyager Therapeutics, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for VYGR, updated each market day.
VYGR AI Sentiment
AI predicts Voyager Therapeutics, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Voyager Therapeutics, Inc. Common Stock
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
Sector
Exchange
Market Cap
$236,013,525
Cap Tier
Employees
141
Headquarters
LEXINGTON, MA
Listed Since
Nov. 11, 2015
VYGR Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
VYGR Volatility
Voyager Therapeutics, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
